Janus kinase inhibitors have proved their worth in treating rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease. Do they perform as well in axial spondyloarthritis?
Janus kinase inhibitors have proved their worth in treating rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease. Do they perform as well in axial spondyloarthritis?
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
